Short and Medium-Term Evaluation of Patients in Coronary Post-Angioplasty: Préliminary results at the Cardiology Department of the Hospital University Aristide Le Dantec of Dakar (Senegal): Study on 38 Cases

Main Article Content

Dioum M*
Aw F
Masmoudi K
Gaye ND
Sarr SA
Ndao SCT
Mingou J
Ngaidé AA
Diack B
Bodian M
Ndiaye MB
Ndiaye MB
Diao M
Ba SA

Abstract

Introduction: Coronary angioplasty is a safe therapeutic method for coronary disease. However, its major obstacles remain the occurrence of stent thrombosis (ST) and in-stent restenosis (ISR). The aim of this study was to evaluate the short-term and medium-term results of coronary angioplasty patients in the cardiology department of Aristide Le Dantec hospital in Dakar.


Methodology: It was a longitudinal, descriptive and analytical study over a period of 12 months (April 2014 to April 2015) with a follow-up at 6 months. Was included any patient who had a coronary angioplasty with stent placement.


Results: Thirty-eight patients had been included with a male predominance and a sex ratio of 5.32. The average age was 57.94 years. Cardiovascular risk factors were mainly smoking (57.9%) and coronary heredity (42.1%), followed by hypertension (39.5%) and diabete (34.2%). The indications for angioplasty were acute coronary syndromes TS(+) and TS(-) respectively (50%) and (23.7%) and stable angina (26.3%). The right femoral approach was almost exclusive (97.4%). Coronary angiography revealed a predominance of anterior interventricular affection (84.2%). Type B lesions were the most frequent (68.4%). The single-truncal valve affection was predominant (76.3%). Direct stenting accounted for 63.2% of procedures. Twenty-one bare stents (55.3%) and 17 active stents (44.7%) were implanted. The results were excellent (94.7%). One case of acute stent thrombosis was noted. Echocardiography of dobutamine stress during follow-up was positive in 04 patients (12.5%). The control coronary angiography performed in two patients revealed an ISR. The predictive factors for restenosis were dominated by a deterioration in the segmental kinetics (p=0.009), in the diastolic function (p=0.002), the systolic function (p=0.003), a high post angioplasty troponin (p=0.004), the presence of calcifications (p=0.004) and a high SYNTAX score (p=0.021).


Conclusion: According to these results, Angioplasty is an effective therapy for coronary disease. However, a correct intake of double platelet antiaggregants and clinical and non-invasive screening are required for follow-up to avoid stent thrombosis or restenosis.

Article Details

M, D., F, A., K, M., ND, G., SA, S., SCT, N., … SA, B. (2017). Short and Medium-Term Evaluation of Patients in Coronary Post-Angioplasty: Préliminary results at the Cardiology Department of the Hospital University Aristide Le Dantec of Dakar (Senegal): Study on 38 Cases. Journal of Cardiology and Cardiovascular Medicine, 2(1), 008–012. https://doi.org/10.29328/journal.jccm.1001006
Case Reports

Copyright (c) 2017 Dioum M, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

WHO. The top 10 causes of death. 2013; Cité 30. Disponible sur: Ref.: https://goo.gl/bLfjF2

Maboury Diao, Serigne Abdou B. Maladies cardio-vasculaires et complications. CHU le Dantecm, Dakar-Sénégal 2013. Ref.: https://goo.gl/KgXNvJ

Philippe F, Dibie A, Larrazet F, Meziane T, Folliguet T et al. Les stents à élution de médicaments: preuves, incertitudes et pratiques. Ann Cardiol Angéiol. 2005; 54: 201-211. Ref.: https://goo.gl/ascnp5

Chevalier B, Blanchard D, Berland J, Carrié D, Gilard M et al. Endoprothèses actives: Indications, limites et développements. Arch Mal Coeur Vaiss. 2005; 98: 1013-1021. Ref.: https://goo.gl/CuHW2l

Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle EA, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998; 31: 1291-1298. Ref.: https://goo.gl/smViit

Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol. 1999; 34: 1067-1074. Ref.: https://goo.gl/8YghtL

Schiele F. Predictive factors of restenosis: what changes with "active" stents? Pathology Biology. 2004; 52: 206-211. Ref.: https://goo.gl/RAkuK4

Zouaoui W, Ouldzein H, Boudou N, Dumonteil N, Bongard V, et al. Factors predictive for in-hospital mortality following percutaneous coronary intervention. Arch Cardiovasc Dis. 2008; 101: 443-448. Ref.: https://goo.gl/MxVZQH

Wilensky RL, Selzer F, Johnston J, Laskey WK, Klugherz BD, et al. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry). Am J Cardiol. 2002; 90: 216-221. Ref.: https://goo.gl/XDUHkh

Assali AR, Moustapha A, Sdringola S, Salloum J, Awadalla H et al. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv. 2003; 59: 195-199. Ref.: https://goo.gl/3wtkA1

Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. The French Registry of Acute ST Elevation or Non-ST-Elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss. 2007; 100: 524-534. Ref.: https://goo.gl/yHc6nN

Ko DT, Atzema CL, Donovan LR, Graham MM, Huynh T. Rescue Percutaneous Coronary Interventions for Failed Fibrinolytic Therapy in ST-segment Elevation Myocardial Infarction. Am Heart J. 2011; 161: 764-770. Ref.: https://goo.gl/46D3YW

Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC), the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010; 31: 2541-2619. Ref.: https://goo.gl/tfUL2t

Chevalier B. American recommendations on coronary angioplasty. Consensus Cardio. 2012; 78: 1-4.

Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Eng J Med. 1994; 331: 489-495. Ref.: https://goo.gl/Mk8PT0

Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II). Lancet. 1998; 352: 673-681. Ref.: https://goo.gl/fWcRre

Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, et al. Clinical Restenosis After Coronary Stenting: Perspectives From Multicenter Clinical Trials. J Am Coll Cardiol. 2002; 40: 2082-2089. Ref.: https://goo.gl/aOD490